<?xml version="1.0" encoding="UTF-8"?>
<ref id="B12-pharmaceutics-10-00247" class="ref">
 <label class="label">12.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Yang</surname>
    <given-names class="given-names">S.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Biowaiver extension potential and IVIVC for BCS Class II drugs by formulation design: Case study for cyclosporine self-microemulsifying formulation</article-title>
  <source class="source">Arch. Pharm. Res.</source>
  <year class="year">2010</year>
  <volume class="volume">33</volume>
  <fpage class="fpage">1835</fpage>
  <lpage class="lpage">1842</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1007/s12272-010-1116-2</pub-id>
  <?supplied-pmid 21116787?>
  <pub-id pub-id-type="pmid" class="pub-id">21116787</pub-id>
 </element-citation>
</ref>
